These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16848669)

  • 1. Memantine for disruptive behavior in autistic disorder.
    Erickson CA; Chambers JE
    J Clin Psychiatry; 2006 Jun; 67(6):1000. PubMed ID: 16848669
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing disruptive and compulsive behaviors in adult with autistic disorder with gabapentin.
    Guglielmo R; Ioime L; Grandinetti P; Janiri L
    J Clin Psychopharmacol; 2013 Apr; 33(2):273-4. PubMed ID: 23422383
    [No Abstract]   [Full Text] [Related]  

  • 3. Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism.
    Niederhofer H
    J Clin Psychopharmacol; 2007 Jun; 27(3):317-8. PubMed ID: 17502791
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxcarbazepine in youths with autistic disorder and significant disruptive behaviors.
    Kapetanovic S
    Am J Psychiatry; 2007 May; 164(5):832-3. PubMed ID: 17475749
    [No Abstract]   [Full Text] [Related]  

  • 5. Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats.
    Kumar H; Sharma B
    Brain Res Bull; 2016 Jun; 124():27-39. PubMed ID: 27034117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating autism pharmacologically: also tacrine might improve symptomatology in some cases.
    Niederhofer H
    J Child Neurol; 2007 Aug; 22(8):1054; author reply 1054-5. PubMed ID: 17761662
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.
    Aman MG; Findling RL; Hardan AY; Hendren RL; Melmed RD; Kehinde-Nelson O; Hsu HA; Trugman JM; Palmer RH; Graham SM; Gage AT; Perhach JL; Katz E
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):403-412. PubMed ID: 26978327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine for comorbid obsessive-compulsive disorder and Asperger disorder suggests a link in glutamatergic dysregulation.
    Bernhardt EB; Walsh KH; Posey DJ; McDougle CJ
    J Clin Psychopharmacol; 2011 Oct; 31(5):673-5. PubMed ID: 21881459
    [No Abstract]   [Full Text] [Related]  

  • 9. Catatonia Delirium: 3 Cases Treated With Memantine.
    Roy K; Warnick SJ; Balon R
    Psychosomatics; 2016; 57(6):645-650. PubMed ID: 27692655
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic therapies aid treatment for autism.
    Lindsay RL; Aman MG
    Pediatr Ann; 2003 Oct; 32(10):671-6. PubMed ID: 14606217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of progressive relaxation training on the disruptive behavior of a boy with autism.
    Mullins JL; Christian L
    Res Dev Disabil; 2001; 22(6):449-62. PubMed ID: 11768670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of directive and nondirective prompts on noncompliant vocal behavior exhibited by a child with autism.
    Peyton RT; Lindauer SE; Richman DM
    J Appl Behav Anal; 2005; 38(2):251-5. PubMed ID: 16033173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Little behavior improvement with memantine].
    Potz-Biedermann C
    Med Monatsschr Pharm; 2005 Nov; 28(11):413-4. PubMed ID: 16309030
    [No Abstract]   [Full Text] [Related]  

  • 14. Medication-induced hypomania in Asperger's disorder.
    Storch DD
    J Am Acad Child Adolesc Psychiatry; 1999 Feb; 38(2):110-1. PubMed ID: 9951203
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketamine followed by memantine for the treatment of major depression.
    Kollmar R; Markovic K; Thürauf N; Schmitt H; Kornhuber J
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514
    [No Abstract]   [Full Text] [Related]  

  • 16. Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder.
    Teng CT; Demetrio FN
    Braz J Psychiatry; 2006 Sep; 28(3):252-4. PubMed ID: 17063225
    [No Abstract]   [Full Text] [Related]  

  • 17. Memantine in the treatment of dementia.
    Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
    Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
    [No Abstract]   [Full Text] [Related]  

  • 18. Memantine and catatonic schizophrenia.
    Thomas C; Carroll BT; Maley RT; Jayanti K; Koduri A
    Am J Psychiatry; 2005 Mar; 162(3):626. PubMed ID: 15741490
    [No Abstract]   [Full Text] [Related]  

  • 19. Memantine in the preventive treatment for migraine and refractory migraine.
    Krymchantowski A; Jevoux C
    Headache; 2009 Mar; 49(3):481-2. PubMed ID: 19280698
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimanic and mood-stabilizing effect of memantine as an augmenting agent in treatment-resistant bipolar disorder.
    Koukopoulos A; Reginaldi D; Serra G; Koukopoulos A; Sani G; Serra G
    Bipolar Disord; 2010 May; 12(3):348-9. PubMed ID: 20565444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.